This document discusses drugs and medications in pregnancy. It begins by outlining the objectives of providing an overview of drug metabolism during pregnancy, discussing principles of teratogenicity, and examining the risk to the fetus from some prescription medications, environmental exposures, and illicit drugs. It then covers how maternal physiology changes during pregnancy can impact drug absorption, distribution, metabolism, and elimination. Key principles of teratology and criteria for defining teratogenicity are presented. Finally, several known or suspected teratogens like alcohol, antiepileptics, ACE inhibitors, antineoplastics, and cocaine are examined in more detail.
This document summarizes drugs in pregnancy, including metabolism changes during pregnancy, effects of drugs on fetuses, teratology evaluation, classifications of medicines by the FDA, counseling for drug exposure, known teratogens, and commonly used drugs in pregnancy. Key points covered include the most sensitive periods for fetuses, FDA drug classifications, counseling for drug exposure, and evaluating drug effects on fetuses. A quiz at the end tests knowledge on drug choices for conditions in pregnancy and emphasizing risks to a woman on warfarin.
Teratology is the study of birth defects and their causes. Some key points:
- Around 5% of newborns have a detectable birth defect, though the cause is unknown for 70% of cases. Less than 1% are due to medications.
- Teratogens are agents that cause permanent changes to embryonic or fetal development, and can cause malformations (teratogen), altered growth (trophogen), or interference with organ maturation (hadegen).
- Studying teratogenicity in humans is difficult due to ethical concerns, so animal studies are also used but not definitive. Counseling women exposed to potential teratogens is important to avoid anxiety.
Sodium valproate is contraindicated in pregnancy due to significant risks of congenital malformations and developmental effects in infants exposed to it in utero. The risk of congenital malformations has been estimated between 6-12% for infants exposed to sodium valproate, compared to background rates of 2-3%. Children exposed to valproate in utero also face risks of reduced IQ, autism spectrum disorder (around 4% risk), and behavioral issues. While reducing valproate doses below 1000 mg/day and using high-dose folate around conception may lower some risks, sodium valproate should generally not be used in women who could become pregnant unless other treatments are ineffective or not tolerated due to its serious
Teratogenicity and the drugs causing itTheDReamer3
brief description about the concept of teratogenicity, brief history , drugs that cause the malformations,studies & screening tests related to it, regulations, guidelines and recent updates.
Teratogens are agents that can cause abnormalities in fetuses or children after birth due to maternal exposure during pregnancy. Common teratogens include certain medications, radiation, infections, and chemicals. They can directly damage the fetus, compromise placental function by restricting blood flow, or trigger contractions. The FDA categorizes pregnancy risks of medications. Category D and X drugs should generally be avoided as they pose the highest risks. Several classes of antibiotics, including tetracyclines, chloramphenicol, aminoglycosides, and sulfonamides/trimethoprim can be teratogenic depending on the specific drug and trimester of exposure.
This document discusses drugs in pregnancy and their effects. It covers several key points:
1) Over 50% of pregnant women take prescribed, over-the-counter, or illicit drugs which can harm the fetus if not absolutely necessary. About 2-3% of birth defects result from necessary drugs.
2) Drugs undergo changes in pharmacokinetics in the maternal-fetal unit, affecting transfer across the placenta and to breastmilk. Factors like molecular weight and protein binding influence transfer.
3) Timing of exposure is important - drugs in early organogenesis often cause birth defects, while later exposure can impact growth and function. FDA categories denote risk. Many drugs are categorized as
drugs safety in pregnancy medications medication in pregnancy treatment during pregnancy healthy pregnancy teratogen teratogenecity teratogenic drugs in pregnancy drugs and congenital malformation
Journal club anticonvulsivantes 13-03-2012Ruber Arias
This document summarizes research on the risk of birth defects in infants born to women taking antiepileptic drugs (AEDs) during pregnancy. It describes a study that compared the risk of major malformations in infants exposed to lamotrigine or carbamazepine as monotherapy or polytherapy during the first trimester. The study found the risk was highest with polytherapy, including polytherapies containing valproate, and lowest with lamotrigine monotherapy. It discusses limitations but concludes the findings provide useful information for counseling women on AED fetal risks.
This document summarizes drugs in pregnancy, including metabolism changes during pregnancy, effects of drugs on fetuses, teratology evaluation, classifications of medicines by the FDA, counseling for drug exposure, known teratogens, and commonly used drugs in pregnancy. Key points covered include the most sensitive periods for fetuses, FDA drug classifications, counseling for drug exposure, and evaluating drug effects on fetuses. A quiz at the end tests knowledge on drug choices for conditions in pregnancy and emphasizing risks to a woman on warfarin.
Teratology is the study of birth defects and their causes. Some key points:
- Around 5% of newborns have a detectable birth defect, though the cause is unknown for 70% of cases. Less than 1% are due to medications.
- Teratogens are agents that cause permanent changes to embryonic or fetal development, and can cause malformations (teratogen), altered growth (trophogen), or interference with organ maturation (hadegen).
- Studying teratogenicity in humans is difficult due to ethical concerns, so animal studies are also used but not definitive. Counseling women exposed to potential teratogens is important to avoid anxiety.
Sodium valproate is contraindicated in pregnancy due to significant risks of congenital malformations and developmental effects in infants exposed to it in utero. The risk of congenital malformations has been estimated between 6-12% for infants exposed to sodium valproate, compared to background rates of 2-3%. Children exposed to valproate in utero also face risks of reduced IQ, autism spectrum disorder (around 4% risk), and behavioral issues. While reducing valproate doses below 1000 mg/day and using high-dose folate around conception may lower some risks, sodium valproate should generally not be used in women who could become pregnant unless other treatments are ineffective or not tolerated due to its serious
Teratogenicity and the drugs causing itTheDReamer3
brief description about the concept of teratogenicity, brief history , drugs that cause the malformations,studies & screening tests related to it, regulations, guidelines and recent updates.
Teratogens are agents that can cause abnormalities in fetuses or children after birth due to maternal exposure during pregnancy. Common teratogens include certain medications, radiation, infections, and chemicals. They can directly damage the fetus, compromise placental function by restricting blood flow, or trigger contractions. The FDA categorizes pregnancy risks of medications. Category D and X drugs should generally be avoided as they pose the highest risks. Several classes of antibiotics, including tetracyclines, chloramphenicol, aminoglycosides, and sulfonamides/trimethoprim can be teratogenic depending on the specific drug and trimester of exposure.
This document discusses drugs in pregnancy and their effects. It covers several key points:
1) Over 50% of pregnant women take prescribed, over-the-counter, or illicit drugs which can harm the fetus if not absolutely necessary. About 2-3% of birth defects result from necessary drugs.
2) Drugs undergo changes in pharmacokinetics in the maternal-fetal unit, affecting transfer across the placenta and to breastmilk. Factors like molecular weight and protein binding influence transfer.
3) Timing of exposure is important - drugs in early organogenesis often cause birth defects, while later exposure can impact growth and function. FDA categories denote risk. Many drugs are categorized as
drugs safety in pregnancy medications medication in pregnancy treatment during pregnancy healthy pregnancy teratogen teratogenecity teratogenic drugs in pregnancy drugs and congenital malformation
Journal club anticonvulsivantes 13-03-2012Ruber Arias
This document summarizes research on the risk of birth defects in infants born to women taking antiepileptic drugs (AEDs) during pregnancy. It describes a study that compared the risk of major malformations in infants exposed to lamotrigine or carbamazepine as monotherapy or polytherapy during the first trimester. The study found the risk was highest with polytherapy, including polytherapies containing valproate, and lowest with lamotrigine monotherapy. It discusses limitations but concludes the findings provide useful information for counseling women on AED fetal risks.
The document discusses the treatment of leukemia in pregnant women. There are two main options - therapeutic abortion or managing the leukemia with close collaboration between obstetric, neonatology, and maternal teams. Treatment decisions must balance risks to the mother and fetus. Acute leukemias are most common and cannot be delayed indefinitely. Outcomes for acute myeloid leukemia treatment during pregnancy are similar to non-pregnant patients if started promptly. Risks of fetal abnormalities are greatest in the first trimester and decrease in the second and third trimesters. Induction chemotherapy can be used in the second or third trimesters with monitoring for abnormalities and fetal cardiac function.
This document provides an overview of neurology topics related to pregnancy, including diagnostic imaging, pre-existing neurological diseases like epilepsy and myasthenia gravis, and their management during pregnancy. It discusses safety of different imaging modalities in pregnancy, effects of pregnancy on diseases and their treatment, risks to the mother and fetus, and recommendations to minimize risks. Medication management is addressed for various conditions, focusing on maintaining seizure control and myasthenia gravis remission while minimizing fetal risks.
Microbial agents like rubella virus, cytomegalovirus, toxoplasma gondii, and Treponema pallidum can cause birth defects when a woman is exposed during pregnancy. These microbes may directly damage the fetus or disrupt the immune response. Common effects include premature birth, growth problems, neurological abnormalities, and damage to organs like the eyes, liver, heart and ears. While exposure to ionizing radiation is a potential risk, most diagnostic procedures expose the fetus to less than 50 mSv of radiation, which is a dose unlikely to increase risks. Prescription drugs are also a concern, as several classes of medications like tetracyclines, chloramphenicol, and anticonvulsants
This document discusses drug use in pregnancy. It notes that until the 20th century, doctors believed the uterus shielded the fetus, but thalidomide caused birth defects, showing drugs can affect the fetus. The fetal period from weeks 3-8 post-conception has the greatest risk of malformations. Most drugs cross the placenta. Minimizing drug use, dose, and number is advised. Teratogens can cause structural abnormalities or functional impairments. The risk must be balanced with treating medical conditions in the mother.
This document provides guidance on preconception counseling and risk assessment. It discusses identifying risks to a woman's health from medical, behavioral, genetic and social factors. The summary provides:
1. Preconception counseling aims to help maintain a woman's well-being, assess any conditions or risks, and achieve a healthy outcome for both mother and baby.
2. Risks are identified through history, examination, and tests, covering topics like age, lifestyle, medical conditions, genetics, and family history.
3. Women at risk are encouraged to prepare for a healthy pregnancy through addressing issues like nutrition, weight, medical conditions, and social support.
This document discusses fetal growth disorders including intrauterine growth restriction (IUGR). It defines key terms like SGA, discusses causes and risk factors for IUGR like placental insufficiency. It outlines methods for detecting and monitoring IUGR fetuses including ultrasound measurements and Doppler assessments. It also presents a staging system for managing IUGR pregnancies based on ultrasound and Doppler findings with recommendations for surveillance and timing of delivery.
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019Võ Tá Sơn
This document provides an overview of fetal growth restriction (FGR), including terminology, prevalence, etiology, diagnostic tools, and guidance for management and delivery timing. It defines FGR as an estimated fetal weight below the 10th percentile and small for gestational age (SGA) as a birth weight below the 10th percentile. FGR can result from maternal medical conditions, substance use, malnutrition, infection, genetic/structural fetal issues, or placental dysfunction. Diagnosis relies on ultrasound to measure fetal size and check for signs of placental insufficiency. Management may include increased surveillance and determining optimal delivery timing to improve neonatal outcomes.
This document discusses drugs used during pregnancy, including their effects, risks, and FDA categories. It covers topics like pharmacokinetics and pharmacodynamics changes during pregnancy, placental transfer of drugs, and effects on the fetus including teratogenesis. Specific commonly used drug classes are mentioned for treating conditions like asthma, hypertension, epilepsy and diabetes in pregnancy. The risks and safety categories of many individual drugs are provided. The goal is to provide an overview while discussing important considerations for drug use during this critical period.
This document discusses teratogens, which are agents that can disturb fetal development and cause birth defects. It notes that birth defects occur in 3-5% of births and are a major cause of infant mortality. Teratogens can directly damage the fetus, compromise the placenta and blood flow to the fetus, or trigger premature labor. The document then categorizes various drugs from A-X based on risks in pregnancy and provides examples of specific drugs like warfarin, penicillamine and corticosteroids that are teratogenic, indicating the trimesters of risk and common associated birth defects. It stresses preventing teratogen exposure during early pregnancy.
Radiation protection course for radiologists L4Amin Amin
1) Radiation exposure during weeks 8-15 of pregnancy poses the highest risk of detrimental effects like mental retardation and congenital abnormalities for the unborn child. Doses higher than 1Sv can cause abnormalities or death, while much lower doses may cause mental retardation.
2) The pre-implantation and organogenesis stages (weeks 2-9) are the most radiosensitive periods, as radiation exposure can cause embryonic or fetal death. During organogenesis, abnormalities are also more likely.
3) During the fetal growth stage, risks include mental retardation, diminished IQ, and increased risk of cancer induction depending on the trimester of exposure. Threshold doses exist for deterministic effects while stochastic effects like cancer have no
This document discusses various categories of drugs and their potential teratogenic effects. It notes that Category A drugs have no risk, Category B have no risk in animal studies but inadequate human studies, Category C have potential risks that may outweigh benefits, Category D have proven risks but benefits may outweigh, and Category X are contraindicated. It provides numerous examples of specific drugs that fall into each category and potential fetal effects, such as heart defects from ACE inhibitors, limb defects from retinoids, and hearing loss from aminoglycosides. It emphasizes careful consideration of risks and benefits for the mother and fetus.
The document discusses the teratogenicity of psychotropic drugs. It notes that while mental illness in mothers poses risks, discontinuing medication during pregnancy may not be possible. The guiding principles are to minimize exposure to untreated illness and psychotropics, continue prior effective medications, and monitor infants for potential drug effects if exposed during lactation or late pregnancy. Risks include teratogenesis, perinatal effects, and potential long-term neurodevelopmental impacts, though studies have shown mixed results. Among SSRIs, paroxetine carries greater risks while sertraline and citalopram generally pose less risk and are considered first-line treatments.
This document discusses drug use and its effects during pregnancy. It notes that pregnancy affects the pharmacokinetics and pharmacodynamics of drugs as every system in the body is impacted by pregnancy. Specifically, absorption and distribution of drugs is increased during pregnancy due to changes in gastric emptying, tissue perfusion, increased total body water and plasma volume. Metabolism and elimination of drugs is also impacted, with renal elimination of drugs doubling during pregnancy. The document outlines various factors that influence how drugs cross the placenta and subsequently impact the fetus, such as lipid solubility, molecular size, placental transporters, and placental and fetal drug metabolism. It also discusses therapeutic drug actions in the fetus as well as predictable and ter
This document discusses prenatal screening methods for detecting congenital abnormalities and genetic disorders. It covers:
1. Various prenatal screening tests for neural tube defects like spina bifida and aneuploidies like Down syndrome including maternal serum screening, ultrasound, and amniocentesis.
2. Risk factors, prevention, and screening candidates for neural tube defects which can be reduced by folic acid supplementation.
3. First trimester screening includes measuring nuchal translucency and maternal serum markers like hCG and PAPP-A levels to detect aneuploidies.
This document discusses protozoan infections and their treatment with antiprotozoal drugs. It describes the life cycles and symptoms of various protozoan diseases including malaria, amoebiasis, leishmaniasis, trypanosomiasis, trichomoniasis, and giardiasis. It provides details on commonly used antiprotozoal drugs, their mechanisms of action, pharmacokinetics, indications, contraindications, adverse effects, and nursing considerations for patients taking these medications. Physical assessment and monitoring of patients is important due to potential central nervous system and gastrointestinal side effects of the drugs.
This document discusses drug use during pregnancy and lactation. It notes that drug use requires special consideration as both the mother and child are affected. During the first trimester, drugs can cause birth defects, and later in pregnancy they can impact fetal growth or development. The principles of therapy are to only use medications when clearly needed, starting with non-drug options, and using the lowest effective dose for shortest time. The document categorizes drugs from A to X based on safety in pregnancy, with Category X posing the greatest risk to the fetus. It also covers common pregnancy issues and medications that may be used to treat them.
Hereditary blood disease is common in Bahrain due to consanguinity marriage. Fighting it is both costly and takes hard efforts. The presentation talks about Thalassemia and Bahrain's experience in combating it.
The document discusses epilepsy and pregnancy, outlining several key points:
1. The aims of treatment for epileptic women who are pregnant are to control seizures, prevent obstetric complications, and ensure adequate neonatal outcomes.
2. Babies born to epileptic mothers face higher risks of seizures, developmental issues, and birth defects ranging from 4-8% compared to 2-3% in the general population.
3. Folic acid supplementation and monotherapy with antiepileptic drugs can help reduce risks, but all drugs studied still show major malformation rates of at least 6%. Close monitoring is important for both mother and baby.
This document outlines a lecture on pediatric infective endocarditis. It discusses the epidemiology, etiology, pathogenesis, clinical manifestations, differential diagnosis, and management of IE in children. Some key points include: congenital heart disease is the most common risk factor; viridans streptococci and staphylococci are frequent causes; clinical features can include fever, heart failure, and neurological symptoms; and diagnosis involves considering other conditions like sepsis, myocarditis, or rheumatologic disorders.
This document outlines key aspects of infection prevention and control in pediatric medicine. It discusses the importance of hand hygiene, standard precautions like the use of barriers, and isolation protocols depending on the transmission route. Surgical prophylaxis is also covered, describing different wound classifications and antibiotic use. Additional measures mentioned include aseptic technique, catheter care, environmental cleansing, and reporting of infections. The overall goal is to reduce healthcare-associated infections in children through appropriate techniques.
The document discusses the treatment of leukemia in pregnant women. There are two main options - therapeutic abortion or managing the leukemia with close collaboration between obstetric, neonatology, and maternal teams. Treatment decisions must balance risks to the mother and fetus. Acute leukemias are most common and cannot be delayed indefinitely. Outcomes for acute myeloid leukemia treatment during pregnancy are similar to non-pregnant patients if started promptly. Risks of fetal abnormalities are greatest in the first trimester and decrease in the second and third trimesters. Induction chemotherapy can be used in the second or third trimesters with monitoring for abnormalities and fetal cardiac function.
This document provides an overview of neurology topics related to pregnancy, including diagnostic imaging, pre-existing neurological diseases like epilepsy and myasthenia gravis, and their management during pregnancy. It discusses safety of different imaging modalities in pregnancy, effects of pregnancy on diseases and their treatment, risks to the mother and fetus, and recommendations to minimize risks. Medication management is addressed for various conditions, focusing on maintaining seizure control and myasthenia gravis remission while minimizing fetal risks.
Microbial agents like rubella virus, cytomegalovirus, toxoplasma gondii, and Treponema pallidum can cause birth defects when a woman is exposed during pregnancy. These microbes may directly damage the fetus or disrupt the immune response. Common effects include premature birth, growth problems, neurological abnormalities, and damage to organs like the eyes, liver, heart and ears. While exposure to ionizing radiation is a potential risk, most diagnostic procedures expose the fetus to less than 50 mSv of radiation, which is a dose unlikely to increase risks. Prescription drugs are also a concern, as several classes of medications like tetracyclines, chloramphenicol, and anticonvulsants
This document discusses drug use in pregnancy. It notes that until the 20th century, doctors believed the uterus shielded the fetus, but thalidomide caused birth defects, showing drugs can affect the fetus. The fetal period from weeks 3-8 post-conception has the greatest risk of malformations. Most drugs cross the placenta. Minimizing drug use, dose, and number is advised. Teratogens can cause structural abnormalities or functional impairments. The risk must be balanced with treating medical conditions in the mother.
This document provides guidance on preconception counseling and risk assessment. It discusses identifying risks to a woman's health from medical, behavioral, genetic and social factors. The summary provides:
1. Preconception counseling aims to help maintain a woman's well-being, assess any conditions or risks, and achieve a healthy outcome for both mother and baby.
2. Risks are identified through history, examination, and tests, covering topics like age, lifestyle, medical conditions, genetics, and family history.
3. Women at risk are encouraged to prepare for a healthy pregnancy through addressing issues like nutrition, weight, medical conditions, and social support.
This document discusses fetal growth disorders including intrauterine growth restriction (IUGR). It defines key terms like SGA, discusses causes and risk factors for IUGR like placental insufficiency. It outlines methods for detecting and monitoring IUGR fetuses including ultrasound measurements and Doppler assessments. It also presents a staging system for managing IUGR pregnancies based on ultrasound and Doppler findings with recommendations for surveillance and timing of delivery.
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019Võ Tá Sơn
This document provides an overview of fetal growth restriction (FGR), including terminology, prevalence, etiology, diagnostic tools, and guidance for management and delivery timing. It defines FGR as an estimated fetal weight below the 10th percentile and small for gestational age (SGA) as a birth weight below the 10th percentile. FGR can result from maternal medical conditions, substance use, malnutrition, infection, genetic/structural fetal issues, or placental dysfunction. Diagnosis relies on ultrasound to measure fetal size and check for signs of placental insufficiency. Management may include increased surveillance and determining optimal delivery timing to improve neonatal outcomes.
This document discusses drugs used during pregnancy, including their effects, risks, and FDA categories. It covers topics like pharmacokinetics and pharmacodynamics changes during pregnancy, placental transfer of drugs, and effects on the fetus including teratogenesis. Specific commonly used drug classes are mentioned for treating conditions like asthma, hypertension, epilepsy and diabetes in pregnancy. The risks and safety categories of many individual drugs are provided. The goal is to provide an overview while discussing important considerations for drug use during this critical period.
This document discusses teratogens, which are agents that can disturb fetal development and cause birth defects. It notes that birth defects occur in 3-5% of births and are a major cause of infant mortality. Teratogens can directly damage the fetus, compromise the placenta and blood flow to the fetus, or trigger premature labor. The document then categorizes various drugs from A-X based on risks in pregnancy and provides examples of specific drugs like warfarin, penicillamine and corticosteroids that are teratogenic, indicating the trimesters of risk and common associated birth defects. It stresses preventing teratogen exposure during early pregnancy.
Radiation protection course for radiologists L4Amin Amin
1) Radiation exposure during weeks 8-15 of pregnancy poses the highest risk of detrimental effects like mental retardation and congenital abnormalities for the unborn child. Doses higher than 1Sv can cause abnormalities or death, while much lower doses may cause mental retardation.
2) The pre-implantation and organogenesis stages (weeks 2-9) are the most radiosensitive periods, as radiation exposure can cause embryonic or fetal death. During organogenesis, abnormalities are also more likely.
3) During the fetal growth stage, risks include mental retardation, diminished IQ, and increased risk of cancer induction depending on the trimester of exposure. Threshold doses exist for deterministic effects while stochastic effects like cancer have no
This document discusses various categories of drugs and their potential teratogenic effects. It notes that Category A drugs have no risk, Category B have no risk in animal studies but inadequate human studies, Category C have potential risks that may outweigh benefits, Category D have proven risks but benefits may outweigh, and Category X are contraindicated. It provides numerous examples of specific drugs that fall into each category and potential fetal effects, such as heart defects from ACE inhibitors, limb defects from retinoids, and hearing loss from aminoglycosides. It emphasizes careful consideration of risks and benefits for the mother and fetus.
The document discusses the teratogenicity of psychotropic drugs. It notes that while mental illness in mothers poses risks, discontinuing medication during pregnancy may not be possible. The guiding principles are to minimize exposure to untreated illness and psychotropics, continue prior effective medications, and monitor infants for potential drug effects if exposed during lactation or late pregnancy. Risks include teratogenesis, perinatal effects, and potential long-term neurodevelopmental impacts, though studies have shown mixed results. Among SSRIs, paroxetine carries greater risks while sertraline and citalopram generally pose less risk and are considered first-line treatments.
This document discusses drug use and its effects during pregnancy. It notes that pregnancy affects the pharmacokinetics and pharmacodynamics of drugs as every system in the body is impacted by pregnancy. Specifically, absorption and distribution of drugs is increased during pregnancy due to changes in gastric emptying, tissue perfusion, increased total body water and plasma volume. Metabolism and elimination of drugs is also impacted, with renal elimination of drugs doubling during pregnancy. The document outlines various factors that influence how drugs cross the placenta and subsequently impact the fetus, such as lipid solubility, molecular size, placental transporters, and placental and fetal drug metabolism. It also discusses therapeutic drug actions in the fetus as well as predictable and ter
This document discusses prenatal screening methods for detecting congenital abnormalities and genetic disorders. It covers:
1. Various prenatal screening tests for neural tube defects like spina bifida and aneuploidies like Down syndrome including maternal serum screening, ultrasound, and amniocentesis.
2. Risk factors, prevention, and screening candidates for neural tube defects which can be reduced by folic acid supplementation.
3. First trimester screening includes measuring nuchal translucency and maternal serum markers like hCG and PAPP-A levels to detect aneuploidies.
This document discusses protozoan infections and their treatment with antiprotozoal drugs. It describes the life cycles and symptoms of various protozoan diseases including malaria, amoebiasis, leishmaniasis, trypanosomiasis, trichomoniasis, and giardiasis. It provides details on commonly used antiprotozoal drugs, their mechanisms of action, pharmacokinetics, indications, contraindications, adverse effects, and nursing considerations for patients taking these medications. Physical assessment and monitoring of patients is important due to potential central nervous system and gastrointestinal side effects of the drugs.
This document discusses drug use during pregnancy and lactation. It notes that drug use requires special consideration as both the mother and child are affected. During the first trimester, drugs can cause birth defects, and later in pregnancy they can impact fetal growth or development. The principles of therapy are to only use medications when clearly needed, starting with non-drug options, and using the lowest effective dose for shortest time. The document categorizes drugs from A to X based on safety in pregnancy, with Category X posing the greatest risk to the fetus. It also covers common pregnancy issues and medications that may be used to treat them.
Hereditary blood disease is common in Bahrain due to consanguinity marriage. Fighting it is both costly and takes hard efforts. The presentation talks about Thalassemia and Bahrain's experience in combating it.
The document discusses epilepsy and pregnancy, outlining several key points:
1. The aims of treatment for epileptic women who are pregnant are to control seizures, prevent obstetric complications, and ensure adequate neonatal outcomes.
2. Babies born to epileptic mothers face higher risks of seizures, developmental issues, and birth defects ranging from 4-8% compared to 2-3% in the general population.
3. Folic acid supplementation and monotherapy with antiepileptic drugs can help reduce risks, but all drugs studied still show major malformation rates of at least 6%. Close monitoring is important for both mother and baby.
Similar to Drugs & Medications In Pregnancy.pptx (20)
This document outlines a lecture on pediatric infective endocarditis. It discusses the epidemiology, etiology, pathogenesis, clinical manifestations, differential diagnosis, and management of IE in children. Some key points include: congenital heart disease is the most common risk factor; viridans streptococci and staphylococci are frequent causes; clinical features can include fever, heart failure, and neurological symptoms; and diagnosis involves considering other conditions like sepsis, myocarditis, or rheumatologic disorders.
This document outlines key aspects of infection prevention and control in pediatric medicine. It discusses the importance of hand hygiene, standard precautions like the use of barriers, and isolation protocols depending on the transmission route. Surgical prophylaxis is also covered, describing different wound classifications and antibiotic use. Additional measures mentioned include aseptic technique, catheter care, environmental cleansing, and reporting of infections. The overall goal is to reduce healthcare-associated infections in children through appropriate techniques.
This document contains the neonatal history of a 6 day old female infant named Baby Zigyibelu. It includes demographic and background information on the mother and father. It describes the pregnancy, delivery, and initial postpartum course. It then provides a thorough physical exam finding for each body system. The infant is growing appropriately with no significant findings noted on exam.
Cyanotic congenital heart diseases are those associated with central cyanosis. This document discusses cyanosis, its causes and influence of hemoglobin level. It also covers consequences of cyanosis like polycythemia and complications. Tetralogy of Fallot and transposition of the great arteries, two common cyanotic congenital heart diseases, are described in detail including their pathophysiology, clinical features, investigations, management and prognosis. Congenitally corrected transposition of the great arteries is also briefly discussed.
C1 lecture Breast complementary feeding.pptxyilkalmossie1
The document discusses breastfeeding and complementary feeding recommendations for infants and children. It provides guidelines on exclusive breastfeeding for the first 6 months, continued breastfeeding with solid foods introduced between 6-24 months, and assessing adequate breastfeeding. The document also outlines potential feeding problems in the first year like underfeeding, overfeeding, and colic, and recommends introducing cereals, fruits and vegetables between 6-8 months as complementary foods.
This document provides an overview of chronic obstructive pulmonary disease (COPD). It defines COPD and related terms like chronic bronchitis and emphysema. It then discusses the epidemiology, pathogenesis, pathologic changes, clinical characterization, diagnosis, assessment of severity and staging, differential diagnosis, and principles of management of COPD. The key points are that COPD is characterized by persistent respiratory symptoms and airflow limitation caused by exposure to noxious particles/gases. Cigarette smoking is the most common risk factor globally. The major pathophysiology involves inflammation and narrowing of the small airways leading to decreased airflow. Spirometry is the gold standard for diagnosis and assessment of severity. Management involves assessing/monitoring
Bronchial Asthma_C I medical students lecture.pptxyilkalmossie1
Bronchial Asthma is a common chronic disease characterized by airway inflammation and variable airflow obstruction. It affects 300 million people worldwide. The goals of asthma management are to achieve symptom control and minimize future risks through a partnership between patient and healthcare providers using a stepwise treatment approach. Initial controller treatment for most asthmatics is a low-dose inhaled corticosteroid. The addition of a long-acting beta agonist to an inhaled corticosteroid provides better asthma control, lung function and reduces exacerbation risk compared to higher dose corticosteroid alone.
This document discusses various cardiac arrhythmias including their mechanisms and treatment. It begins by describing the three main mechanisms of cardiac arrhythmia: alterations in impulse initiation (automaticity), afterdepolarizations and triggered automaticity, and abnormal impulse conduction (reentry). It then discusses various specific arrhythmias in more detail, including types of heart block, tachycardias like atrial fibrillation, flutter and sinus tachycardia, as well as treatment options like antiarrhythmic drugs, catheter ablation, and pacemakers. In summary, the document provides an overview of the conduction system of the heart and covers the pathophysiology, classification, evaluation and management of different cardiac arrhythmias.
Cardiomyopathies are diseases of the heart muscle that are not caused by hypertension, coronary artery disease, valvular or pericardial abnormalities. They can be classified as primary (involving the myocardium of unknown cause) or secondary (caused by a systemic disease).
The document discusses the main types of cardiomyopathy - dilated, hypertrophic and restrictive. It provides details on their definitions, causes, clinical features, diagnostic evaluations and treatments. Dilated cardiomyopathy is the most common and causes ventricular enlargement and impaired systolic function. Hypertrophic cardiomyopathy causes disproportionate left ventricular hypertrophy. Restrictive cardiomyopathy results in stiff ventricles that impede filling.
This patient is a 30-year-old man who presented with altered mental status, headache, and left-side body weakness. He has a history of recently diagnosed HIV. On examination, he has a low GCS, hypertonic limbs, and neck stiffness. Differential diagnoses include cryptococcal meningitis, tuberculous meningitis, and aseptic meningitis. Diagnostic workup should include lumbar puncture, blood tests, and brain imaging to determine the specific type of meningitis and guide treatment.
Here are the key points to include in the history for a patient presenting with an anterior neck swelling:
- Duration of swelling - how long they've had it and if it has changed over time
- How they first noticed it and if it has spread/enlarged
- Any pressure symptoms - difficulty breathing, swallowing, etc.
- Symptoms of hyperthyroidism or hypothyroidism - sweating, palpitations, weight changes, etc.
- Relationship between swelling and any symptoms - if symptoms came before, after, or at the same time
- Family history of thyroid problems
- Medications - amiodarone, lithium which can cause goiter
- Diet - iodine
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyR3 Stem Cell
Dr. David Greene, founder and CEO of R3 Stem Cell, is at the forefront of groundbreaking research in the field of cardiology, focusing on the transformative potential of stem cell therapy. His latest work emphasizes innovative approaches to treating heart disease, aiming to repair damaged heart tissue and improve heart function through the use of advanced stem cell techniques. This research promises not only to enhance the quality of life for patients with chronic heart conditions but also to pave the way for new, more effective treatments. Dr. Greene's work is notable for its focus on safety, efficacy, and the potential to significantly reduce the need for invasive surgeries and long-term medication, positioning stem cell therapy as a key player in the future of cardiac care.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
1. Drugs & Medications In
Pregnancy
Tesfaye A.
( MD, Obstetrician & Gynecologist )
2/13/2023 1
2. Objectives
Give overview on drug metabolism in pregnancy
Discuss principles of teratogenicity
Discuss risk to the fetus from some of prescription
medicines, environmental exposure & illicit drugs
2/13/2023 2
3. Maternal Physiology During Pregnancy
• Evolves during the course of pregnancy
CVS & Pulmonary-
Renal – increased renal plasma flow & GFR
Hepatic- higher portal venous return
GI - N &V , decreased intestinal motility
2/13/2023 3
4. Effect Of Physiologic Changes On Drug Metabolism
1) Drug absorption
- the slower intestinal motility and decreased gastric acid secretion
- no confirmatory evidence for increased oral bioavailability
2) Drug distribution
- decreased plasma protein ( albumin & AAG)
- increased free fraction , increased clearance
3) Drug metabolism
- Phase I & Phase II
- Activity of majority of enzymes in cytochrome P450 (CYP) system
increases during pregnancy (impacted by maternal genotype)
4) Drug Elimination
- changes in renal clearance during pregnancy varies widely
2/13/2023 4
6. • Passive diffusion across the villous barrier –predominant
method of the fetus’s exposure
- Small
- lipid soluble, Cross the placenta easily
- unionized, and
- poorly protein
bound
2/13/2023 6
8. Principles Of Teratology
Teratology - the study of birth defects and their etiology
Teratogen - may be defined as any agent that act
during embryonic or fetal development
to produce a permanent alteration of
form or function.
2/13/2023 8
10. Wilson’s six general
principles of teratogenesis
1. Genotype interaction with environmental factors
2. Timing of exposure
3. Mechanisms of teratogens
4. Manifestation
5. Agent
6. Dose effect
2/13/2023 10
12. Fetal risks with maternal pharmacotherapy
The overall risk of congenital malformations is 2–4%.
However, only 10% of malformations are linked to
drug exposure
Administration of drugs early may affect the heart or neural tube;
Later exposure affects the formation of the ear and palate.
Before day 31, exposure to a teratogen produces an
all-or-none effect, ( fertilization to implantation)
2/13/2023 12
13. Criteria To Define Teratogenicity
• Established exposure of the embryo or fetus at a critical
time during development.
• Consistent dysmorphic findings recognized in well conducted
epidemiologic studies.
• Specific defects or syndromes consistently associated with
a specific teratogen
2/13/2023 13
14. Studies in pregnant women
▪ Case reports or series,
- single case reports which later aggregated
- true risk posed by various drugs and environmental agents.
▪ Case-control studies,
- cases & controls are compared for exposure
▪ Cohort studies
- groups differing in exposure be followed through time,
with outcomes observed.
▪ RCTs- lacking ,unless for evaluating efficiency of prevention or treatment
2/13/2023 14
15. ▪ Pregnancy Registries
- monitoring potentially harmful agents
- requires knowledge of the baseline prevalence
of that anomaly in the population
2/13/2023 15
16. Counseling for medication exposure
• Individuals tend to exaggerate potential risks associated with
medication exposure.
• The manner in which information is presented affects perception.
• Negative vs positive information
• Odds ratio vs absolute risk
2/13/2023 16
18. Limitation of letter classification
- Mainly, it is for prescribing physician
- Can lead to overreliance
- higher letter grade did not necessarily mean greater risk
- drugs in the same category often had very different risks
- < 1% category A. while most had no safety data in humans ( category C)
- Does not address inadvertent exposure
2/13/2023 18
19. Known / Suspected teratogens
1. Alcohol
- No amount of alcohol can be considered safe in pregnancy
- Spectrum of alcohol-related fetal defects known as fetal alcohol syndrome
- CNS abnormalities,
- pre- or postnatal growth impairment, and a
- characteristic pattern of minor facial abnormalities
- In 6% of infants of heavy drinkers
2/13/2023 19
21. 2. Antiepileptic
• The most frequently reported anomalies are orofacial clefts, cardiac
malformations, and neural-tube defects
• valproic acid confers the greatest risk
• -The risk for fetal malformations is approximately
doubled if multiple agents are required
• Several older anticonvulsants also produce a constellation of
malformations similar to the fetal hydantoin syndrome
• The benefits of AEDs in appropriates doses during pregnancy outweigh
the risks of discontinuation.
2/13/2023 21
23. •These risks do not appear to hold for the newer
agents levetiracetam and lamotrigine, although
the number of reported pregnancies to date is
smaller
•
2/13/2023 23
25. 5.NSAIDs
- Indomethacin – Constriction of DA,..
- ASA-
6. Leflunomide
- In several animal species, it results in fetal hydrocephalus,
eye anomalies, skeletal abnormalities, and embryo death
when given at or below human-equivalent doses
- The active metabolite, teriflunomide, is detectable in plasma for
up to 2 years following discontinuation of the medication
- What if a woman becomes pregnant while taking it ?
2/13/2023 25
26. 7. Antimicrobials –most are safe except;
- aminoglycosides- some preterm neonates developed
ototoxicity &nephrotoxicity
- chloramphenicol - avoided in late pregnancy due to
theoretical concerns.
- Tetracyclines – are associated with yellowish-brown discoloration
of deciduous teeth when used after 25 weeks’ gestation.
2/13/2023 26
27. 8.Antineoplastic agents
- Cyclophosphamide- high-arched palate, microcephaly, flat nasal bridge,
syndactyly, hypoplasia of the finger, secondary malignancy
- Methotrexate –conotruncal cardiac defect, facial & limb anomalies
,abortion
- Tamoxifen – DES exposure like syndrome in animals
- Trastuzumab - cases of oligohydramnios sequence resulting in pulmonary
hypoplasia, renal failure, skeletal abnormalities, and neonatal deaths have
been reported
2/13/2023 27
28. 9. Anti virals
▪ For most ,experience in pregnancy is limited
▪ Ribavrin – causes multiple birth defects in different animal species
- skeletal , eye ,palate, GI abnormalities
- women should be on contraceptive for 6 months
after discontinuation of the drug
- contraindicated in men whose partners are pregnant.
2/13/2023 28
29. Efaverinz - CNS and ocular abnormalities in cynomolgus monkeys
- Antiretroviral Pregnancy Registry has identified
no increased birth defect rates in more than
800 pregnancies with first-trimester exposure
2/13/2023 29
30. 10. Androgens- cause varying degrees of virilization and may
result in ambiguous genitalia
Danazole- There was a dose-related pattern of clitoromegaly,
fused labia, and urogenital sinus malformation.
( In a review of inadvertent exposure during early
pregnancy when given , 9-12 weeks after conception )
2/13/2023 30
31. 11. Immunosuppressant Medications
• Corticosteroids – other vs prednisolone
• A meta-analysis of exposure to corticosteroids in the fist trimester
showed an odds ratio of 3.0 for cleft lip and/or cleft palate.
2/13/2023 31
32. 12. Radioiodine – contraindicated in pregnancy
- Pregnancy testing should be
performed before administration
of radioiodine-131.
- no fetal risk for exposure before 12 weeks of gestation
.
2/13/2023 32
33. Mercury – environmental spillage
- consumption of certain species of large fish
2/13/2023 33
34. 13. Psychiatric medications
Lithium
- has been associated with Ebstein anomaly
- These women should be offered appropriate
prenatal diagnosis with ultrasound, including
fetal echocardiography.
- may be withheld for 24 to 48 hours before
delivery to reduce both neonatal complications
2/13/2023 34
35. • A 1.5- to twofold greater risk for cardiac malformations
following first-trimester paroxetine exposure
• Late pregnancy exposure - neonatal behavioral syndrome , ? PPHN
• Antipsychotic – are not considered teratogenic
2/13/2023 35
36. 14. Retinoids
- are among the most potent human teratogens
- The prevalence of birth defects after exposure
during embryogenesis is estimated to be as high as 30%
- cause abortion, CNS malformations, cardiac , facial
dysmorphism, etc.
2/13/2023 36
37. 15.Thalidomide and Lenalidomide
- Possibly the most notorious human teratogen
- causes malformations in 20 percent of fetuses exposed between
34 and 50 days menstrual age.
- The characteristic malformation is phocomelia
- was instructive of several important teratological principles
2/13/2023 37
38. 16. Warfarin
• Warfarin embryopathy
- nasal hypoplasia, microphthalmia ,hypoplasia of extremities ,IUGR,
cardiac defects ,deafness, mental retardation
- stippled epiphyses
• following exposure during this critical period is estimated to be 6 percent
▪ One embryopathy met analysis , warfarin dosage was ≤5 mg/d identified
in 1 percent of exposed fetuses.
▪ This suggests that risk may be dose dependent
2/13/2023 38
39. • Abnormalities can also include agenesis of the corpus
callosum; cerebellar vermin agenesis, which is the Dandy-Walker
malformation; microphthalmia; and optic atrophy
2/13/2023 39
40. 17. Cocaine –
• With this CNS stimulant, most adverse outcomes result from its
vasoconstrictive and hypertensive effects
• Fetal-growth restriction and preterm delivery.
• Children exposed as fetuses have risks for behavioral abnormalities
and cognitive impairments
2/13/2023 40
Nonetheless, studies of drugs with high ratesof hepatic extraction show variable effects on their systemicavailability
Pharmacokinetics – what the body does on the drug
Thus, a teratogen may be a medication or other chemical substance, aphysical or environmental factor such as heat or radiation, a maternal metabolite asin diabetes or phenylketonuria, or an infection such as cytomegalovirus. Evenobesity is considered a teratogen
This can manifesteither structurally or functionally [98] and malformationscan vary in severity from being life threatening, to havingserious cosmetic or functional consequences
When teratogens are specially damaging
different genetic strains of mice vary greatly in their susceptibility toteratogens that lead to oral clefts. Some of the variability in responsesto antiepileptic drugs (AEDs), like valproic acid and phenytoin, probablyrelates to the genotype of the embryo.For example, neural tube defects (NTDs) mayresult from exposure between 22 and 28 days postconception. Thalidomide teratogenicity differs as a function of the developmental stage atexposureThe fourth principle is that irrespective of the specifi deleteriousagent, the fial manifestations of abnormal development are death,malformation, growth restriction, and/or functional disorder
For example, thalidomide is harmless in several animal species but resulted inphocomelia in thousands of children born across Europe in the late 1950s and early1960sThalidomide, sold under the brand names Contergan and Thalomid among others, is a medication used to treat a number of cancers (including multiple myeloma), ...
Shepard (2002a) recommended thatestablishment of teratogenicity in this way requires proven exposure at a criticaltime in development and probably at least three such cases, each carefullydelineated.
There are websites where detailed information about drugs is found.
One of these anecdotes was an alleged Carthaginian lawforbidding bridal couples to drink wine on their weddingnight so as to avoid the conception of defective children
This included a 4-percent risk for neural-tube defects(Hernandez-Diaz, 2012). School-aged children with in utero exposure to valproicacid have poorer cognitive development—including significantly lowerintelligence quotient (IQ) scores—than children exposed to other antiepilepticdrugs (Bromley, 2014; Meador, 2009).Valproic acid monotherapy signifiantly increases the riskfor spina bifia (odds ratio [OR], 12.7), atrial septal defect (OR, 2.5),cleft palate (OR, 5.2), hypospadias (OR, 4.8), polydactyly (OR, 2.2),and craniosynostosis (OR, 6.8).16 A high daily dose or a combinationof two or three of these drugs increases the chance of malformations.
Phenytoin -congenital heart defects and cleft palate
Effective drugs for high blood pressure & kidney disease
Embryo toxicity ??although thesehave largely been disproven.Thus, women with inadvertentfirst-trimester exposure to these medications can be reassured
can causefetal renal tubular dysplasia in the second and third trimesters, leadingto oligohydramnios, fetal limb contractures, craniofacial deformities,and hypoplastic lung development. Fetal skull ossifiation defects havealso been described. For these reasons, women on these medicationswho plan pregnancy should be switched to other agents.
Thereforeamoxicillin/clavulanate should be avoided in women at risk for pretermdelivery.
Monoclonal anti human growth factor receptor 2
For hep C infection
TDF + 3TC+ EFV . THEN TDF+3TC+DTG
Unlike other corticosteroids, the active metabolite of prednisone, which is prednisolone, is inactivated by the placental enzyme 11β-hydroxysteroiddehydrogenase 2. Thus, it may not effectively reach the fetus.
Radioactive iodine (131I or 125I) administered for thyroid ablationor for diagnostic studies is not concentrated by the fetal thyroid untilafter 12 weeks of gestation. Thus, with inadvertent exposure before12 weeks, there is no specifi risk to the fetal thyroid from 131I or 125Iadministration
avoid consumption of king mackerel,marlin, orange roughy, shark, swordfish, tilefish, and bigeye tuna.
American College of Obstetricians and Gynecologists (2016)recommends that paroxetine be avoided in women planning pregnancy. Fetalechocardiography should be considered for those with first-trimester paroxetineexposure.